AAAAAA

   
Results: 1-22 |
Results: 22
Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients
Authors: Borawski, J Mysliwiec, M
Citation: J. Borawski et M. Mysliwiec, Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients, CL APPL T-H, 7(4), 2001, pp. 296-299
A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients
Authors: Hryszko, T Malyszko, J Malyszko, JS Brzosko, S Pawlak, K Mysliwiec, M
Citation: T. Hryszko et al., A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients, NEPH DIAL T, 16(8), 2001, pp. 1692-1696
Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response
Authors: Borawski, J Naumnik, B Pawlak, K Mysliwiec, M
Citation: J. Borawski et al., Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response, NEPH DIAL T, 16(7), 2001, pp. 1442-1447
Soluble thrombomodulin is associated with viral hepatitis, blood pressure,and medications in haemodialysis patients
Authors: Borawski, J Naumnik, B Pawlak, K Mysliwiec, M
Citation: J. Borawski et al., Soluble thrombomodulin is associated with viral hepatitis, blood pressure,and medications in haemodialysis patients, NEPH DIAL T, 16(4), 2001, pp. 787-792
Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients
Authors: Brzosko, S Lebkowska, U Malyszko, J Hryszko, T Pawlak, K Mysliwiec, M
Citation: S. Brzosko et al., Correlation between carotid intima-media thickness and hematocrit and hemoglobin values in renal transplant recipients, CLIN TRANSP, 15(5), 2001, pp. 349-353
Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis
Authors: Malyszko, J Malyszko, JS Mysliwiec, M
Citation: J. Malyszko et al., Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis, PERIT DIA I, 21(2), 2001, pp. 158-165
Simvastain affects TAFI and thrombomodulin in CAPD patients
Authors: Malyszko, J Malyszko, JS Hryszko, T Mysliwiec, M
Citation: J. Malyszko et al., Simvastain affects TAFI and thrombomodulin in CAPD patients, THROMB HAEM, 86(3), 2001, pp. 930-931
Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients
Authors: Malyszko, J Malyszko, JS Hryszko, T Mysliwiec, M
Citation: J. Malyszko et al., Effects of long-term treatment with simvastatin on some hemostatic parameters in continuous ambulatory peritoneal dialysis patients, AM J NEPHR, 21(5), 2001, pp. 373-377
Homocysteinemia in patients with type 1 diabetes in relation to renal function
Authors: Brzosko, S Mysliwiec, M Donati, MB Iacoviello, L
Citation: S. Brzosko et al., Homocysteinemia in patients with type 1 diabetes in relation to renal function, DIABET CARE, 24(12), 2001, pp. 2158-2158
Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor
Authors: Hryszko, T Malyszko, J Malyszko, JS Brzosko, S Mysliwiec, M
Citation: T. Hryszko et al., Patients on peritoneal dialysis but not on hemodialysis have elevated concentration and activity of thrombin-activatable fibrinolysis inhibitor, THROMB RES, 104(4), 2001, pp. 233-238
The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients
Authors: Borawski, J Mysliwiec, M
Citation: J. Borawski et M. Mysliwiec, The hematocrit-corrected erythrocyte sedimentation rate can be useful in diagnosing inflammation in hemodialysis patients, NEPHRON, 89(4), 2001, pp. 381-383
Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzedand peritoneally dialyzed patients
Authors: Malyszko, J Wolczynski, S Zbroch, E Brzosko, S Malyszko, J Mysliwiec, M
Citation: J. Malyszko et al., Serum crosslaps correlations with serum ICTP and urine DPD in hemodialyzedand peritoneally dialyzed patients, NEPHRON, 87(3), 2001, pp. 283-285
Comparison of different assays for von Willebrand factor in hemodialysis patients
Authors: Borawski, J Pawlak, K Mysliwiec, M
Citation: J. Borawski et al., Comparison of different assays for von Willebrand factor in hemodialysis patients, HAEMOSTASIS, 30(6), 2000, pp. 308-315
Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy
Authors: Malyszko, J Zbroch, E Wolczynski, S Malyszko, JS Hryszko, T Mysliwiec, M
Citation: J. Malyszko et al., Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy, AM J NEPHR, 20(3), 2000, pp. 180-186
Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months
Authors: Malyszko, JS Malyszko, J Mysliwiec, M
Citation: Js. Malyszko et al., Serum lipids and hemostasis in kidney allograft recipients treated with fluvastatin (Lescol) for 3 months, TRANSPLAN P, 32(6), 2000, pp. 1344-1346
Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro
Authors: Malyszko, J Malyszko, JS Mysliwiec, M
Citation: J. Malyszko et al., Effects of mycophenolate mofetil and mycophenolic acid on platelet aggregation in vitro, TRANSPLAN P, 32(6), 2000, pp. 1347-1349
Peripheral serotonergic system in hemodialyzed and peritoneally dialyzed patients
Authors: Malyszko, J Pawlak, D Malyszko, J Buczko, W Mysliwiec, M
Citation: J. Malyszko et al., Peripheral serotonergic system in hemodialyzed and peritoneally dialyzed patients, NEPHRON, 86(3), 2000, pp. 396-397
Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin
Authors: Malyszko, JS Malyszko, J Pawlak, K Pawlak, D Buczko, W Mysliwiec, M
Citation: Js. Malyszko et al., Importance of serotonergic mechanisms in the thrombotic complications in hemodialyzed patients treated with erythropoietin, NEPHRON, 84(4), 2000, pp. 305-311
Leptinaemia in patients dialysed with different buffers and dialysis membranes
Authors: Malyszko, J Zbroch, E Wolczynski, S Malyszko, JS Mysliwiec, M
Citation: J. Malyszko et al., Leptinaemia in patients dialysed with different buffers and dialysis membranes, NEPH DIAL T, 14(10), 1999, pp. 2527-2529
Tissue factor and tissue factor pathway inhibitor in kidney allograft recipients
Authors: Malyszko, JS Malyszko, J Mysliwiec, M
Citation: Js. Malyszko et al., Tissue factor and tissue factor pathway inhibitor in kidney allograft recipients, TRANSPLAN P, 31(5), 1999, pp. 2118-2120
L-carnitine effects on anemia in uremic rats treated with erythropoietin
Authors: Azzadin, A Wollny, T Pawlak, R Malyszko, JS Malyszko, J Mysliwiec, M Buczko, W
Citation: A. Azzadin et al., L-carnitine effects on anemia in uremic rats treated with erythropoietin, NEPHRON, 83(4), 1999, pp. 370-371
15-deoxyspergualin and platelet aggregation in vitro
Authors: Malyszko, JS Malyszko, J Mysliwiec, M Takada, A
Citation: Js. Malyszko et al., 15-deoxyspergualin and platelet aggregation in vitro, NEPHRON, 81(3), 1999, pp. 370-372
Risultati: 1-22 |